Orikami

Orikami is a Dutch MedTech organization specializing in applied data science to enable personalized healthcare, with a stated mission to improve 100 million lives before 2030. The company focuses on developing and implementing digital biomarkers for people with chronic diseases. Digital biomarkers are defined as objective, quantifiable physiological and behavioral data collected and measured by digital devices such as wearables, portables, implantables, or digestibles. By using real-world patient data, Orikami aims to create personalized healthcare paths for clients, ultimately improving their quality of life. The clinical validation of these digital biomarkers provides objective data that yields clinically significant results, which in turn supports decision-making for clinicians and optimizes patient health paths. The company believes that health data is currently underutilized and their solutions contribute to innovating healthcare and increasing the efficiency of healthcare ecosystems.